CD8A and cancer: Conversely, IDO1 knockdown restored the percentage of Granzyme B+ CD8+ T cells and reduced the frequency of CD25+FOXP3+ CD4+ T cells within tumor tissues derived from USP14-overexpressing cancer cells.